Skip to main content Skip to navigation
Purified Mouse Anti-MLC2a
Purified Mouse Anti-MLC2a

Immunohistochemical staining of MLC2a in human left atrium and left ventricle Following antigen retrieval with BD Retrievagen A buffer (Cat. No. 550524), the formalin-fixed paraffin-embedded sections were stained with either Purified Mouse IgG1, κ Isotype Control (Cat. No. 550878; top left) or Purified Mouse Anti-MLC2a (top right) on left atrium. Additionally, Purified Mouse Anti-MLC2a (bottom left) and Purified Mouse Anti-MLC2v (Cat. No. 565497, bottom right) were used to stain left ventricle. A three-step staining procedure that employs Biotin Goat Anti-Mouse Ig (Cat. No. 550337), Streptavidin HRP (Cat. No.550946), and the DAB Substrate Kit (Cat. No. 550880) was used to develop the primary staining reagents. The tissues were counterstained with Hematoxylin. Original magnification: 40X (MLC2a) and 20X (MLC2v).

詳細を表示
0.1 mg
製品詳細
Down Arrow


BD Pharmingen™
MLC-2a; myosin regulatory light chain 7; MYL7; MYL2A; MYLC2A
Human (QC Testing), Mouse (Predicted)
Mouse IgG1, κ
Human MLC2a Recombinant Protein
Intracellular staining (flow cytometry) (Routinely Tested), Bioimaging, Immunofluorescence, Immunohistochemistry-formalin (antigen retrieval required), Western blot (Tested During Development)
28 kDa
0.5 mg/ml
AB_2739265
Aqueous buffered solution containing ≤0.09% sodium azide.
RUO


Product Notices

  1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
  2. Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
  3. An isotype control should be used at the same concentration as the antibody of interest.
  4. Sodium azide is a reversible inhibitor of oxidative metabolism; therefore, antibody preparations containing this preservative agent must not be used in cell cultures nor injected into animals. Sodium azide may be removed by washing stained cells or plate-bound antibody or dialyzing soluble antibody in sodium azide-free buffer. Since endotoxin may also affect the results of functional studies, we recommend the NA/LE (No Azide/Low Endotoxin) antibody format, if available, for in vitro and in vivo use.
  5. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.

データシート

565496 Rev. 1
抗体の詳細
Down Arrow
S58-205

Myosin is composed of 2 heavy chains, 2 regulatory light chains, and 2 alkali light chains. The S58-205 monoclonal antibody specifically binds to human Myosin regulatory light chain 2, atrial isoform (MLC2a) that is selectively expressed in the cardiac atrium, while the MLC2v isoform is selectively expressed in the cardiac ventrical. The differential expression of the two MLC2 isoforms is first detected early in cardiogenesis, prior to the formation of distinct atrial and ventrical chambers. During the induction of cardiovascular lineage cells from a human embryonic stem cell line, the appearance of contracting cardiomyocytes is coincident with the up-regulation of the expression of several genes, including the genes encoding MLC2a and MLC2v. Cross-reactivity of the S58-205 monoclonal antibody to mouse MLC2a is predicted due to the ~96% conservation of the human and mouse protein sequences.

565496 Rev. 1
フォーマットの詳細
Down Arrow
Purified
Tissue culture supernatant is purified by either protein A/G or affinity purification methods. Both methods yield antibody in solution that is free of most other soluble proteins, lipids, etc. This format provides pure antibody that is suitable for a number of downstream applications including: secondary labeling for flow cytometry or microscopy, ELISA, Western blot, etc.
Purified
565496 Rev.1
引用&参考文献
Down Arrow

Development References (5)

  1. Dubois NC, Craft AM, Sharma P, et al. SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat Biotechnol. 2011; 29:1011-1018. (Biology). View Reference
  2. Franco D, Lamers WH, Moorman AF. Patterns of expression in the developing myocardium: towards a morphologically integrated transcriptional model. Cardiovasc Res. 1998; 38(1):25-53. (Biology). View Reference
  3. Hailstones D, Barton P, Chan-Thomas P, et al. Differential regulation of the atrial isoforms of the myosin light chains during striated muscle development. J Biol Chem. 1992; 267(32):23295-23300. (Biology). View Reference
  4. Kubalak SW, Miller-Hance WC, O'Brien TX, Dyson E, Chien KR. Chamber specification of atrial myosin light chain-2 expression precedes septation during murine cardiogenesis. J Biol Chem. 1994; 269(24):16961-16970. (Biology). View Reference
  5. Laflamme MA, Murry CE. Heart regeneration. Nature. 2011; 473(7347):326-335. (Biology). View Reference
すべて表示する (5) 表示項目を減らす
565496 Rev. 1

Please refer to Support Documents for Quality Certificates

 

Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described

 

Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims.  Comparisons are not made against non-BD technologies, unless otherwise noted.

For Research Use Only. Not for use in diagnostic or therapeutic procedures.